Bitcoin sets a new all-time high above $6,000 >>> READ MORE

GSK

Recent Articles

Improving Analytics Lift Ranking of GlaxoSmithKline (GSK) to Hold

GlaxoSmithKline Plc (NYSE:GSK) is ranked as a Hold using the system of Louis Navellier for investing and his Portfolio Grader stock evaluator. GSK has been upgraded from a Sell to a Hold in the last week. More 

GlaxoSmithKline (GSK) Keeps Sell Recommendation

Currently, GlaxoSmithKline Plc (NYSE:GSK) has a Sell using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing methodology. GSK has maintained this ranking for 2 months. More 

3 Diverse Dividend Stocks With 6%-Plus Payouts

Looking for income? Here are 3 must-buy high-yield dividend stocks for your portfolio covering diverse industries. More 

Bank on Gilead Sciences, Inc. (GILD) Stock Getting Its Mojo Back

I don't know if Gilead (GILD) actually flipped from being a falling machete to shooting star, but I'm willing to bank on GILD stock. More 

3 Pivotal Drug Trials to Watch for Explosive Potential

Here's a look at three biotech stocks that have at least one treatment prepped to enter pivotal clinical trials soon. More 

GOOGL Stock Is Falling Into a Funk

Alphabet (GOOGL) is in more peril today following a Monday downgrade, as a continued slide has GOOGL stock below important chart support. More 

74 Trades to Make this Week

It pays to stay on top of the latest profit opportunities, and my Portfolio Grader can help inform your trades for the week More